CN115537388A - Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof - Google Patents
Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof Download PDFInfo
- Publication number
- CN115537388A CN115537388A CN202211249948.1A CN202211249948A CN115537388A CN 115537388 A CN115537388 A CN 115537388A CN 202211249948 A CN202211249948 A CN 202211249948A CN 115537388 A CN115537388 A CN 115537388A
- Authority
- CN
- China
- Prior art keywords
- recombinant
- growth factor
- mesenchymal stem
- serum
- bovine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 26
- 235000013372 meat Nutrition 0.000 title claims abstract description 24
- 238000004113 cell culture Methods 0.000 title claims abstract description 23
- 241000283690 Bos taurus Species 0.000 title claims abstract description 20
- 239000012679 serum free medium Substances 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims abstract description 24
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims abstract description 24
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 15
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims abstract description 15
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 15
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 12
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960000890 hydrocortisone Drugs 0.000 claims abstract description 12
- 239000004017 serum-free culture medium Substances 0.000 claims abstract description 12
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 12
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 12
- 239000011781 sodium selenite Substances 0.000 claims abstract description 12
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 claims abstract description 12
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 11
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 11
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims abstract description 11
- 102000013275 Somatomedins Human genes 0.000 claims abstract description 11
- 101001011741 Bos taurus Insulin Proteins 0.000 claims abstract description 10
- 102000004338 Transferrin Human genes 0.000 claims abstract description 10
- 108090000901 Transferrin Proteins 0.000 claims abstract description 10
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 claims abstract description 10
- 239000012581 transferrin Substances 0.000 claims abstract description 10
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims abstract description 6
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims abstract description 6
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims abstract description 5
- 229960002648 alanylglutamine Drugs 0.000 claims abstract description 5
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims abstract description 4
- 102000004877 Insulin Human genes 0.000 claims abstract description 3
- 239000001963 growth medium Substances 0.000 claims description 25
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 5
- 239000007640 basal medium Substances 0.000 claims description 5
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 4
- 229930182816 L-glutamine Natural products 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- 229940054269 sodium pyruvate Drugs 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 8
- 210000004102 animal cell Anatomy 0.000 abstract description 2
- 239000000306 component Substances 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 239000002609 medium Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 5
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000013401 experimental design Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 2
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229960002413 ferric citrate Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 101150088952 IGF1 gene Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 101001055320 Myxine glutinosa Insulin-like growth factor Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008143 early embryonic development Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a serum-free culture medium for bovine adipose-derived mesenchymal stem cells, which is suitable for cell culture meat, belongs to the technical field of animal cell culture, and comprises DMEM basic culture, L-alanyl-L-glutamine, recombinant transferrin, recombinant bovine insulin, sodium selenite, zinc sulfate heptahydrate, cortisol, recombinant human serum albumin, recombinant basic fibroblast growth factor, recombinant transforming growth factor beta 1, recombinant insulin-like growth factor, ethanolamine, mercaptoethanol and 2-phosphoric acid-L-ascorbic acid sodium salt. Repeated experiments prove that the inventor obtains a novel bovine Adipose-derived mesenchymal stem cell (ADSC) serum-free culture medium, and can effectively culture the bovine Adipose mesenchymal stem cells.
Description
Technical Field
The invention belongs to the technical field of animal cell culture, and particularly relates to a bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and a preparation method thereof.
Background
Compared with plant meat and fermented meat made of microorganisms, the cell culture meat is novel meat which is closest to traditional meat. The cell culture meat has the advantages of no microbial pollution, high-quality protein content, good eating experience and the like, and the carbon footprint and water resource requirements in the production process are much lower than those of the traditional livestock breeding, so that the cell culture meat is one of the most promising development directions in the future culture of meat substitutes. Meanwhile, the technical barrier of the cell culture meat industry is also higher and more challenging. Among them, the development of a low-cost animal-derived component-free medium suitable for cell culture meat is an important basis for cell culture meat to meet food safety standards and eventually to be able to enter mass production.
Mesenchymal Stem Cells (MSCs) are derived from the mesoderm in the early embryonic development stage, are adult Stem Cells which have the potential of self-renewal and multidirectional differentiation and can still maintain the biological characteristics thereof after in vitro large-scale amplification, and can proliferate and differentiate to various tissues such as bone, cartilage, muscle, ligament, tendon, fat and stromal Cells. Therefore, mesenchymal stem cells are one of the important cell sources for culturing meat.
At present, the media used to culture MSCs are mainly of the following types: one is a basal medium (such as alpha-MEM medium, DMEM medium, etc.) supplemented with 5-20% animal serum. However, animal serum is expensive and has a limited yield, and is not suitable for large-scale production of cell culture meat. In addition, animal serum may have mycoplasma, prion and other pollution, and human xenoprotein pollution or allergy and other risks, and is difficult to meet edible standards; the second category is the addition of serum replacement (e.g., human platelet lysate, etc.) to basal media. However, the culture medium has animal-derived components, has unknown protein, has the defects of large batch difference, unstable source and the like, and is not suitable for producing cell culture meat on a large scale; the third type is to supplement serum substitute components which are not derived from animals and have definite chemical components in a basal culture medium, so that the nutrient requirement of cells can be met, and the natural defects of the first two types of culture media can be avoided. Therefore, the cell culture medium which is suitable for the growth of the MSCs and has definite chemical formula and low cost is an important prerequisite for the development of large-scale production of cell culture meat.
Disclosure of Invention
Aiming at the existing problems, the inventor obtains a novel serum-free culture medium of bovine Adipose-derived mesenchymal stem cells (ADSCs) through repeated experimental verification, and can effectively culture the bovine Adipose mesenchymal stem cells.
The invention is realized by the following technical scheme:
a bovine adipose-derived mesenchymal stem cell serum-free culture medium suitable for cell culture meat comprises a DMEM basic culture medium, and further comprises the following components and concentrations thereof: 75mg/L of L-alanyl-L-glutamine, 0-5.5mg/L of recombinant transferrin, 0-10mg/L of recombinant bovine insulin, 0.001-0.01mg/L of sodium selenite, 0.1-2mg/L of zinc sulfate heptahydrate, 10-50ng/mL of cortisol, 0.1-1.5mg/mL of recombinant human albumin, 1-10ng/mL of recombinant basic fibroblast growth factor, 1-2 ng/mL of recombinant transforming growth factor beta, 5-20ng/mL of recombinant insulin-like growth factor, 2-100mg/mL of ethanolamine, 0.1-3mg/L of mercaptoethanol and 10-50mg/L of 2-phosphate-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500mg/L D-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
Preferably, the culture medium comprises a DMEM basic culture medium, and further comprises the following components and concentrations thereof: 75mg/L of L-propylamino-L-glutamine, 4mg/L of recombinant transferrin, 8mg/L of recombinant bovine insulin, 0.005mg/L of sodium selenite, 1mg/L of zinc sulfate heptahydrate, 25ng/mL of cortisol, 1.25mg/mL of recombinant human serum albumin, 5ng/mL of recombinant basic fibroblast growth factor, 1.5 ng/mL of recombinant transforming growth factor beta, 10ng/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 2.2mg/L of mercaptoethanol and 30mg/L of 2-phosphoric acid-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500mg/L D-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
A preparation method of a bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture meat comprises the following steps:
(1) Preparing the corresponding concentrations for later use: 43.5mg/L of L-alanyl-L-glutamine, 1mg/L of recombinant transferrin, 5mg/L of recombinant bovine insulin, 0.4mg/L of sodium selenite, 0.01g/L of zinc sulfate heptahydrate, 0.5mg/mL of cortisol, 0.1g/mL of recombinant human serum albumin, 10 mug/mL of recombinant basic fibroblast growth factor, 100 mug/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 10mg/L of mercaptoethanol and 0.1g/L of sodium 2-phosphate-L-ascorbate;
(2) Filtering with 0.2 μm low protein adsorption filter membrane;
(3) And adding the filtered L-propylamino-L-glutamine, recombinant transferrin, recombinant bovine insulin, sodium selenite, zinc sulfate heptahydrate, cortisol, recombinant human serum albumin, recombinant basic fibroblast growth factor, recombinant transforming growth factor-beta 1, recombinant insulin-like growth factor, ethanolamine, mercaptoethanol and 2-phosphoric acid-L-ascorbic acid sodium salt solution into a DMEM basic culture medium, and uniformly mixing to obtain the serum-free culture medium of the bovine adipose-derived mesenchymal stem cells.
Compared with the prior art, the invention has the following advantages:
1. the culture medium has no animal-derived components, has controllable infection risk and meets the food production standard;
2. the components contained in the culture medium are all derived from recombinant proteins or chemically synthesized, and the components are clear;
3. when the culture medium prepared by the method is applied, a culture dish or a culture bottle does not need to be coated in advance;
4. when the culture medium prepared by the method is applied, the adherence of cells is good, and the cell morphology has no obvious difference with that of serum cultured cells;
5. when the culture medium prepared by the method is applied, the cell proliferation rate is high, the price is relatively low, and the method is suitable for large-scale cell culture.
Drawings
FIG. 1 shows the results of a Plackett-Burman experiment for screening of first batch of medium components;
FIG. 2 shows the results of a Plackett-Burman experiment for the second batch of media composition screening;
FIG. 3 is a graph comparing P7 generation bovine adipose derived mesenchymal stem cells with other brands of serum-free medium and 10% serum medium.
Detailed Description
The present invention will be described in further detail with reference to the accompanying drawings and examples.
The components of the present invention may be selected from conventional commercially available products (Table 1).
TABLE 1 serum-free Medium composition information
Example 1 selection of serum-free Medium Components of bovine adipose-derived mesenchymal Stem cells
The screening method comprises the following steps: two batches of the Plackett-Burman experiment design (tables 2, 3) were run separately for various components in serum-free medium, with 12 treatment groups per batch of the Plackett-Burman experiment, and 3 replicates per treatment group. In the first experiment, two concentration levels of ITS (%), fibronectin (FN, μ g/mL), recombinant human serum albumin (ReHA, mg/mL), recombinant basic fibroblast growth factor (FGF 2, ng/mL), recombinant insulin-like growth factor (IGF 1, ng/mL), recombinant epidermal growth factor (EGF, ng/mL), recombinant transforming growth factor beta 1 (TGF beta 1, ng/mL) and recombinant vascular endothelial growth factor (VEGF, ng/mL) were screened, the concentration levels being determined by reference and earlier experiments.
TABLE 2 first batch Medium composition screening Plackett-Burman Experimental design
Treatment group | ITS | FN | ReHA | FGF2 | IGF1 | EGF | TGFβ1 | VEGF |
1 | 0 | 0 | 0.8 | 10 | 5 | 0 | 0 | 0 |
2 | 5 | 2 | 0.8 | 0 | 0 | 0 | 0 | 5 |
3 | 5 | 2 | 0 | 0 | 5 | 0 | 0.5 | 0 |
4 | 0 | 2 | 0.8 | 0 | 5 | 10 | 0 | 5 |
5 | 0 | 2 | 0.8 | 10 | 0 | 10 | 0.5 | 0 |
6 | 5 | 0 | 0.8 | 0 | 5 | 10 | 0.5 | 0 |
7 | 5 | 0 | 0 | 10 | 5 | 10 | 0 | 5 |
8 | 0 | 0 | 0 | 0 | 0 | 10 | 0.5 | 5 |
9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | 5 | 2 | 0 | 10 | 0 | 10 | 0 | 0 |
11 | 5 | 0 | 0.8 | 10 | 0 | 0 | 0.5 | 5 |
12 | 0 | 2 | 0 | 10 | 5 | 0 | 0.5 | 5 |
After 72h of cell culture with 12 experimental formulations, the cells were counted and the results of 12 treatment groups were analyzed (fig. 1). The results show that the addition of ITS, reHA, FGF2, IGF and TGF beta 1 promotes cell proliferation and is therefore retained in the medium formulation
Two concentration levels of sodium selenite (SS, 0 and 0.01%), ferric citrate (FC, μ g/mL), zinc sulfate heptahydrate (ZnSO 4, mg/L), hydrocortisone (h.c., ng/mL), ethanolamine (ethan., mg/L), mercaptoethanol (EGF, mg/L), HEPES buffer (mg/L) and sodium 2-phospho-L-ascorbate (P _ LAA, μ g/mL) were screened in the second experiment.
TABLE 3 second batch Medium composition screening Plackett-Burman Experimental design
Treatment group | SS | FC | ZnSO4 | H.C. | Ethan. | ME | HEPES | P_LAA |
1 | 0 | 0 | 10 | 25 | 50 | 0 | 0 | 0 |
2 | 0.01 | 2 | 1 | 0 | 0 | 0 | 0 | 20 |
3 | 0.01 | 2 | 0 | 0 | 50 | 0 | 3000 | 0 |
4 | 0 | 2 | 1 | 0 | 50 | 2.2 | 0 | 20 |
5 | 0 | 2 | 1 | 25 | 0 | 2.2 | 3000 | 0 |
6 | 0.01 | 0 | 1 | 0 | 50 | 2.2 | 3000 | 0 |
7 | 0.01 | 0 | 0 | 25 | 50 | 2.2 | 0 | 20 |
8 | 0 | 0 | 0 | 0 | 0 | 2.2 | 3000 | 20 |
9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | 0.01 | 2 | 0 | 25 | 0 | 2.2 | 0 | 0 |
11 | 0.01 | 0 | 1 | 25 | 0 | 0 | 3000 | 20 |
12 | 0 | 2 | 0 | 25 | 50 | 0 | 3000 | 20 |
After 72h of cell culture with 12 experimental formulations, the cells were counted and the results of 12 treatment groups were analyzed (fig. 2). The results show that the addition of sodium selenite, zinc sulfate heptahydrate, hydrocortisone, ethanolamine, mercaptoethanol and sodium 2-phospho-L-ascorbate promotes cell proliferation and is therefore retained in the medium formulation. While ferric citrate and HEPES buffer did not promote in the current formulations and therefore were not retained in the culture medium.
EXAMPLE 2 determination of the proportion of the major constituents of serum-free Medium
After determining each component of the culture medium, the mixture ratio of the components of the culture medium screened in two batches is optimized through two times of orthogonal experimental design (tables 4 and 5). Each time, 12 treatment groups were tested orthogonally, with 3 replicates per treatment group, each component being designed for both high and low concentration levels.
TABLE 4 first orthogonal experimental design
TABLE 5 second orthogonal design of experiment
Treatment group | SS | ZnSO4 | H.C. | Ethan. | ME | P_LAA |
1 | 0.005 | 1 | 25 | 50 | 0.1 | 5 |
2 | 0.01 | 1 | 50 | 2 | 0.1 | 30 |
3 | 0.01 | 2 | 50 | 50 | 0.1 | 5 |
4 | 0.005 | 1 | 50 | 50 | 2.2 | 30 |
5 | 0.005 | 1 | 25 | 2 | 2.2 | 5 |
6 | 0.01 | 1 | 50 | 50 | 2.2 | 5 |
7 | 0.01 | 2 | 25 | 50 | 2.2 | 30 |
8 | 0.005 | 2 | 50 | 2 | 2.2 | 30 |
9 | 0.005 | 2 | 50 | 2 | 0.1 | 5 |
10 | 0.01 | 2 | 25 | 2 | 2.2 | 5 |
11 | 0.01 | 1 | 25 | 2 | 0.1 | 30 |
12 | 0.005 | 2 | 25 | 50 | 0.1 | 30 |
As a result, it was found that: the bovine adipose-derived mesenchymal stem cells cultured by adopting the following mixture ratio have the advantages of optimal shape, higher proliferation efficiency and lower overall cost of the culture medium: the culture medium comprises a DMEM high-glycosyl basic culture medium, 4mg/L of recombinant transferrin, 8mg/L of recombinant bovine insulin, 0.005mg/L of sodium selenite, 1mg/L of zinc sulfate heptahydrate, 25ng/mL of cortisol, 1.25mg/mL of recombinant human serum albumin, 5ng/mL of recombinant basic fibroblast growth factor, 1.5 ng/mL of recombinant transforming growth factor beta, 10ng/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 2.2mg/L of mercaptoethanol and 30mg/L of 2-phospho-L-ascorbic acid sodium salt. In addition, the medium was supplemented with 75mg/L L-propylamino-L-glutamine as a supplemental nitrogen source.
Example 3 comparison of the minimal Medium formulation with serum Medium and commercial serum-free Medium
According to the formula of the culture medium determined by the invention, a serum-free culture medium is prepared. Meanwhile, a conventionally used serum culture medium is prepared: adding fetal calf serum into DMEM high-sugar medium according to the proportion of 10%, and then adding recombinant basic fibroblast growth factor with the concentration of 5 ng/mL. The two culture mediums are compared with a serum-free mesenchymal stem cell culture medium of a certain brand on the market. First, bovine adipose-derived mesenchymal stem cells cultured adherently were digested with 0.25% trypsin, added to two media at a concentration of 3 ten thousand cells per mL, and placed in 12-well plates at a volume of 1mL per well. Placing 12-well culture plates at 37 deg.C, 5% CO 2 And culturing in a cell culture box with saturated humidity, observing the cell state after culturing for 72h, and counting the concentration of living cells. Fig. 3 is a graph comparing P7 generation bovine adipose-derived mesenchymal stem cells cultured in three different media. As can be seen from the figure, the cells cultured by the three culture media are all spindle-shaped and fiber-like, which indicates that the serum-free culture medium can maintain better cell morphology. The cell counting result shows that the serum-free culture medium can reach the same level of the commercial serum-free culture medium in terms of cell proliferation, and the proliferation promoting efficiency is higher than that of a 10% serum culture medium.
Claims (3)
1. The serum-free culture medium for the bovine adipose-derived mesenchymal stem cells is suitable for cell culture of meat, and is characterized by comprising a DMEM basic culture medium and further comprising the following components in concentration: 75mg/L of L-alanyl-L-glutamine, 0-5.5mg/L of recombinant transferrin, 0-10mg/L of recombinant bovine insulin, 0.001-0.01mg/L of sodium selenite, 0.1-2mg/L of zinc sulfate heptahydrate, 10-50ng/mL of cortisol, 0.1-1.5mg/mL of recombinant human albumin, 1-10ng/mL of recombinant basic fibroblast growth factor, 1-2 ng/mL of recombinant transforming growth factor beta, 5-20ng/mL of recombinant insulin-like growth factor, 2-100mg/mL of ethanolamine, 0.1-3mg/L of mercaptoethanol and 10-50mg/L of 2-phosphate-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500mg/L D-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
2. The serum-free culture medium for the bovine adipose-derived mesenchymal stem cells, which is suitable for cell culture of meat, according to claim 1, comprises a DMEM (DMEM) basic culture medium, and further comprises the following components and concentrations thereof: 75mg/L of L-propylamino-L-glutamine, 4mg/L of recombinant transferrin, 8mg/L of recombinant bovine insulin, 0.005mg/L of sodium selenite, 1mg/L of zinc sulfate heptahydrate, 25ng/mL of cortisol, 1.25mg/mL of recombinant human serum albumin, 5ng/mL of recombinant basic fibroblast growth factor, 1.5 ng/mL of recombinant transforming growth factor beta, 10ng/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 2.2mg/L of mercaptoethanol and 30mg/L of 2-phosphoric acid-L-ascorbic acid sodium salt, wherein the DMEM basal medium comprises: 4500 mg/LD-glucose, 3700mg/L sodium bicarbonate, 584mg/L L-glutamine and 110mg/L sodium pyruvate.
3. The method for preparing the serum-free medium for the bovine adipose-derived mesenchymal stem cells suitable for cell culture of meat according to claim 1, which comprises the following steps:
(1) Preparing the corresponding concentrations for later use: 43.5mg/L of L-alanyl-L-glutamine, 1mg/L of recombinant transferrin, 5mg/L of recombinant bovine insulin, 0.4mg/L of sodium selenite, 0.01g/L of zinc sulfate heptahydrate, 0.5mg/mL of cortisol, 0.1g/mL of recombinant human serum albumin, 10 ug/mL of recombinant basic fibroblast growth factor, 100 ug/mL of recombinant insulin-like growth factor, 50mg/mL of ethanolamine, 10mg/L of mercaptoethanol and 0.1g/L of sodium salt of 2-phospho-L-ascorbic acid;
(2) Filtering with 0.2 μm low protein adsorption filter membrane;
(3) And adding the filtered L-propylamino-L-glutamine, recombinant transferrin, recombinant bovine insulin, sodium selenite, zinc sulfate heptahydrate, cortisol, recombinant human serum albumin, recombinant basic fibroblast growth factor, recombinant transforming growth factor-beta 1, recombinant insulin-like growth factor, ethanolamine, mercaptoethanol and 2-phosphoric acid-L-ascorbic acid sodium salt solution into a DMEM basic culture medium, and uniformly mixing to obtain the serum-free culture medium of the bovine adipose-derived mesenchymal stem cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211249948.1A CN115537388A (en) | 2022-10-12 | 2022-10-12 | Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211249948.1A CN115537388A (en) | 2022-10-12 | 2022-10-12 | Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115537388A true CN115537388A (en) | 2022-12-30 |
Family
ID=84732631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211249948.1A Pending CN115537388A (en) | 2022-10-12 | 2022-10-12 | Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115537388A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107557331A (en) * | 2017-09-15 | 2018-01-09 | 上海莱馥医疗科技有限公司 | A kind of method for separating and cultivating human adipose-derived stem cell |
CN110923196A (en) * | 2019-12-03 | 2020-03-27 | 广州赛莱拉干细胞科技股份有限公司 | Serum-free medium, preparation method thereof and mesenchymal stem cell culture method |
CN112608891A (en) * | 2020-12-18 | 2021-04-06 | 云南中科灵长类生物医学重点实验室 | Mesenchymal stem cell serum-free medium and application thereof |
CN113736729A (en) * | 2021-08-25 | 2021-12-03 | 生物岛实验室 | Composition, stem cell serum-free culture medium containing composition and stem cell culture method |
US20220073870A1 (en) * | 2020-06-05 | 2022-03-10 | Upside Foods, Inc. | Nutrient media for the production of slaughter-free meat |
-
2022
- 2022-10-12 CN CN202211249948.1A patent/CN115537388A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107557331A (en) * | 2017-09-15 | 2018-01-09 | 上海莱馥医疗科技有限公司 | A kind of method for separating and cultivating human adipose-derived stem cell |
CN110923196A (en) * | 2019-12-03 | 2020-03-27 | 广州赛莱拉干细胞科技股份有限公司 | Serum-free medium, preparation method thereof and mesenchymal stem cell culture method |
US20220073870A1 (en) * | 2020-06-05 | 2022-03-10 | Upside Foods, Inc. | Nutrient media for the production of slaughter-free meat |
CN112608891A (en) * | 2020-12-18 | 2021-04-06 | 云南中科灵长类生物医学重点实验室 | Mesenchymal stem cell serum-free medium and application thereof |
CN113736729A (en) * | 2021-08-25 | 2021-12-03 | 生物岛实验室 | Composition, stem cell serum-free culture medium containing composition and stem cell culture method |
Non-Patent Citations (2)
Title |
---|
PATRIKOSKI M等: "Development of fully defined xeno-free culture system for the preparation and propagation of cell therapy-compliant human adipose stem cells", 《STEM CELL RES THER》, vol. 04, no. 02, 7 March 2013 (2013-03-07), pages 1 - 15 * |
任春红等: "无动物源成分培养基用于人脐带间充质干细胞培养的研究", 《延安大学学报(医学科学版)》, vol. 13, no. 01, 15 March 2015 (2015-03-15), pages 1 - 4 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Review of the current research on fetal bovine serum and the development of cultured meat | |
CN103911339B (en) | A kind of serum-free fibroblast culture medium and preparation method thereof | |
JP4532493B2 (en) | Cell culture media | |
US20220204923A1 (en) | Chemically defined medium for differentiation of muscle stem cells in vitro | |
IL142914A (en) | Serum free medium for chondrocyte-like cells | |
CN113736729B (en) | Composition, serum-free medium containing composition and stem cell culture method | |
CN112961825B (en) | Serum-free medium and preparation method thereof | |
US20230117670A1 (en) | Bioactive substance composition, serum-free medium comprising the composition, and uses thereof | |
CN112608891A (en) | Mesenchymal stem cell serum-free medium and application thereof | |
US20230083026A1 (en) | Serum-free medium for culturing a bovine progenitor cell | |
CN114480273A (en) | Culture medium for obtaining mesenchymal stem cells and exosomes thereof and preparation method thereof | |
CN111206017A (en) | Serum-free culture medium for stem cells and application thereof | |
CN114574433B (en) | Culture medium with definite chemical components for in-vitro proliferation of myogenic cells | |
WO2003050273A1 (en) | Human cell culture medium and culture method | |
CN110699317A (en) | Human umbilical cord mesenchymal stem cell serum-free medium and preparation method and application thereof | |
CN115537388A (en) | Bovine adipose-derived mesenchymal stem cell serum-free medium suitable for cell culture of meat and preparation method thereof | |
US20240254453A1 (en) | Cell culture medium and supplements for corneal and skin cell culture | |
KR102679956B1 (en) | Method of culturing muscle cells for producing cattle cultured meat | |
CN117957308A (en) | Cell culture medium and supplement for cell meat production | |
CN112708598A (en) | Neural precursor cell culture medium without serum component and preparation method and application thereof | |
CN110684735A (en) | Culture medium for rapidly proliferating neural stem cells | |
CN112126622B (en) | Primary isolated culture method of umbilical cord mesenchymal stem cells capable of improving yield | |
CN117535237A (en) | Human umbilical cord mesenchymal stem cell culture medium and preparation method thereof | |
CN116478914A (en) | Serum-free cell culture system and cell digestion stopping solution thereof | |
CN115896008A (en) | Low-serum culture medium and application thereof in preparation of cell culture meat of large yellow croaker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |